| |
| |
|
| Insider
Information: |
Anderson Bonnie H |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
75,036 |
|
|
Indirect Shares
|
156,523 |
|
|
| Direct
Value |
$1,525,804 |
|
|
|
Indirect Value
|
$2,829,452 |
|
|
| Total
Shares |
231,559 |
|
|
| Total
Value |
$4,355,256 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -33.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Veracyte, Inc. |
VCYT |
Director |
2023-06-02 |
41,377 |
2023-06-02 |
134,800 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2019-07-29 |
23,630 |
2020-07-17 |
21,723 |
Premium* |
|
|
Bruker Corp |
BRKR |
|
2024-01-05 |
10,029 |
2020-09-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
162 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2021-02-24 |
4 |
D |
$62.30 |
$2,460,102 |
D/D |
(39,488) |
164,268 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2021-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
184,268 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2021-03-02 |
4 |
D |
$62.15 |
$392,788 |
D/D |
(6,320) |
177,948 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2021-05-17 |
4 |
OE |
$5.61 |
$78,905 |
D/D |
14,065 |
192,013 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2021-06-02 |
4 |
D |
$36.07 |
$82,528 |
D/D |
(2,288) |
189,725 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2021-09-02 |
4 |
D |
$52.97 |
$121,195 |
D/D |
(2,288) |
64,544 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2021-09-10 |
4 |
AS |
$50.03 |
$95,050 |
I/I |
(1,900) |
220,078 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2021-09-17 |
4 |
AS |
$50.18 |
$130,478 |
I/I |
(2,600) |
217,478 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2021-12-02 |
4 |
D |
$39.22 |
$89,735 |
D/D |
(2,288) |
62,256 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2021-12-09 |
4 |
OE |
$8.86 |
$99,994 |
D/D |
11,286 |
73,542 |
0 |
- |
|
| BRKR |
Bruker Corp |
Director |
– • – |
2022-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,841 |
5,682 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2022-03-02 |
4 |
D |
$27.84 |
$125,865 |
D/D |
(4,521) |
69,021 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
17,667 |
86,688 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2022-05-01 |
4 |
D |
$20.47 |
$15,066 |
D/D |
(736) |
85,952 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2022-06-02 |
4 |
D |
$18.23 |
$37,226 |
D/D |
(2,042) |
67,045 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2022-08-05 |
4 |
S |
$27.71 |
$2,131,370 |
I/I |
(76,917) |
157,426 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2022-08-08 |
4 |
S |
$27.24 |
$1,229,075 |
I/I |
(45,000) |
112,426 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2022-09-02 |
4 |
D |
$19.18 |
$39,166 |
D/D |
(2,042) |
65,003 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2022-10-13 |
4 |
OE |
$8.86 |
$99,996 |
D/D |
11,088 |
76,091 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2022-12-01 |
4 |
OE |
$5.61 |
$885,300 |
D/D |
80,000 |
145,003 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2022-12-01 |
4 |
AS |
$27.81 |
$2,260,748 |
D/D |
(80,000) |
65,003 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Executive Chairwoman |
• • – |
2022-12-02 |
4 |
D |
$29.14 |
$59,504 |
D/D |
(2,042) |
62,961 |
0 |
- |
|
| BRKR |
Bruker Corp |
|
– • – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,970 |
7,652 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2023-01-11 |
4 |
OE |
$14.34 |
$906,962 |
D/D |
63,247 |
126,208 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2023-01-11 |
4 |
AS |
$25.13 |
$1,589,195 |
D/D |
(63,247) |
62,961 |
0 |
% |
|
162 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
